If you cannot view the webcast, click here to download the free Flash Player.

Jointly sponsored by the American Academy of CME, Inc and Princeton CME

Target Audience

This activity is designed for medical directors, consultant pharmacists, and directors of nursing in long-term care facilities. 

Learning Objectives

After completing this activity, participants should be able to:

• Describe the incidence and burden of stroke and transient ischemic attack (TIA) in the long-term care setting
• List the nonpharmacologic and pharmacologic approaches available for secondary prevention of cerebrovascular events
• Explain the common barriers to the use of secondary stroke prevention measures among stroke and TIA survivors in long-term care facilities
• Summarize the recent American Heart Association/American Stroke Association (AHA/ASA) guidelines for the prevention of ischemic stroke in patients who have experienced a previous ischemic stroke or TIA
• Apply the AHA/ASA evidence-based guidelines to improve outcomes in the long-term care setting

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: June 29, 2007; Expiration Date: June 29, 2008

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The audio/video presentation, post-test and evaluation form are available as a click through via the menu at the top of this page.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Academy of CME, Inc and Princeton CME. The American Academy of CME, Inc is accredited by the ACCME to provide continuing medical education for physicians.

The American Academy of CME, Inc designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

To contact the American Academy of CME, Inc, please e-mail dbottinick@academycme.org or call 609-921-6622.

This CME activity is recognized by the American Osteopathic Association for a maximum of 1 Category 2 credit.

CNE Accreditation

The American Academy of CME, Inc is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The American Academy of CME, Inc designates this activity for 1.0 contact hour.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-297-07-018-H01).

Grant Support

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Presenters

Todd Levine, MD
Phoenix Neurological Associates
Director, Samaritan Stroke Center
Clinical Assistant Professor
University of Arizona
Phoenix, Arizona

Paul R. Rasa, RPh, CCP, FASCP
President/CEO, The Rasa Group, Inc.
Independent Pharmaceutical Care Consulting Firm
Ringwood, New Jersey

Independent Clinical Reviewer
John R. Sims II, MD
Assistant Professor, Harvard Medical School
Assistant in Neurology, Massachusetts General Hospital
Division of Stroke and Neurocritical Care
Charlestown, Massachusetts

Disclosure Information

In accordance with the disclosure policies of the American Academy of CME, Inc, and Princeton CME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between faculty and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All faculty members participating in this activity have disclosed all relevant financial relationships with commercial interests. The planners of this activity have reviewed these disclosures and have determined that the faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

The faculty has reported the following:

Dr. Levine: Speakers Bureau—Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Pfizer, Wyeth
Mr. Rasa: Scientific advisory board—Forest Pharmaceuticals, sanofi-aventis; Consulting—Mature Health; Honorarium—IntraMed, Managed Market Resources, Ortho Biotech
Dr. Sims disclosed no relevant financial relationships with any commercial interests.

Planning Committee Debra Bottinick, the American Academy of CME, Inc; Randy Robbin and John Savage, Princeton CME; Rosemary Hodgson and Melissa Berman, Princeton Media Associates have disclosed they have no relevant financial relationships with any commercial interests.

The American Academy of CME, Inc and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.

The faculty will discuss either non-FDA-approved or investigational uses of the following products/devices:  carotid stenting.